KK2260

· Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KK2260, covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors [Phase 1]